Thursday, January 20, 2022

Bharath Biotech

Bharath Biotech refutes charges of irregularities in Covaxin supply to Brazil

This assertion came from Bharath Biotech, after Brazil indicated suspension of its contract with the Hyderabad-based vaccine maker after allegations of irregularities in the deal surfaced.

Exploring all options to procure enough vaccines: KTR

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

Covaxin price cut down to Rs 400 for states

Announcing the price cut on Thursday, the company maintained that it was deeply concerned with the critical pandemic situation in India

Latest News

- Advertisement -